Ledger.Open graph →
SEC Form D · Amendment · filed December 8, 2020

Bond Biosciences, Inc

Offering
$6.0M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Cory A. Berkland · New York, NYExec · DirectorTimothy A. Opler · New York, NYDirectorMichael A. Riley · New York, NYExec · DirectorJustin Ross · Austin, TXExec · DirectorFred Ehrsam · Austin, TXDirectorScott Kavanaugh · Dallas, TXExec · DirectorChad Collishaw · Austin, TXExec · DirectorEddie R. Hutton · SHANNON, MSDirectorCruz Sierra · Austin, TXExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗